" It is thought BBI is working towards a deal in which Brookfiled would buy 50% of BBI's DBCT.
On top of that, BAM would inject a further $600m or so into the company via a capital raising either by underwirring a rights issue or via share placement.
Shareholders will be asked to match the $600 million via an equity raising. BBI would also force the convesrion of the Beppa and Sparc instruments into ords. 25b securities existing equity will represent 10% of recapitalised company/Suggesting huge dilution.
HOWEVER this deal has a few more twists. A consolidation of the shares is a likely factor. There are also strong indications of a few more components to this deal....WHICH WILL ENSURE EXISTING SHAREHOLDERS NOT DILUTED TO THAT LEVEL"_____________________________________________________
I particularly like the last paragraph..GL TO ALL
- Forums
- ASX - By Stock
- BBI
- breaking news ...street talk p22
breaking news ...street talk p22
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BBI (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online